JP2002536329A5 - - Google Patents

Download PDF

Info

Publication number
JP2002536329A5
JP2002536329A5 JP2000596934A JP2000596934A JP2002536329A5 JP 2002536329 A5 JP2002536329 A5 JP 2002536329A5 JP 2000596934 A JP2000596934 A JP 2000596934A JP 2000596934 A JP2000596934 A JP 2000596934A JP 2002536329 A5 JP2002536329 A5 JP 2002536329A5
Authority
JP
Japan
Prior art keywords
methylene
phenylenebis
bis
linker
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000596934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002536329A (ja
JP4968868B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2000/000104 external-priority patent/WO2000045814A1/en
Publication of JP2002536329A publication Critical patent/JP2002536329A/ja
Publication of JP2002536329A5 publication Critical patent/JP2002536329A5/ja
Application granted granted Critical
Publication of JP4968868B2 publication Critical patent/JP4968868B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000596934A 1999-02-02 2000-02-02 白血球数を高めるための方法および組成物 Expired - Fee Related JP4968868B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11825599P 1999-02-02 1999-02-02
US60/118,255 1999-02-02
PCT/CA2000/000104 WO2000045814A1 (en) 1999-02-02 2000-02-02 Methods and compositions to enhance white blood cell count

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011023235A Division JP2011088937A (ja) 1999-02-02 2011-02-04 白血球数を高めるための方法および組成物

Publications (3)

Publication Number Publication Date
JP2002536329A JP2002536329A (ja) 2002-10-29
JP2002536329A5 true JP2002536329A5 (https=) 2007-03-15
JP4968868B2 JP4968868B2 (ja) 2012-07-04

Family

ID=22377471

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000596934A Expired - Fee Related JP4968868B2 (ja) 1999-02-02 2000-02-02 白血球数を高めるための方法および組成物
JP2011023235A Withdrawn JP2011088937A (ja) 1999-02-02 2011-02-04 白血球数を高めるための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011023235A Withdrawn JP2011088937A (ja) 1999-02-02 2011-02-04 白血球数を高めるための方法および組成物

Country Status (24)

Country Link
US (2) US6365583B1 (https=)
EP (1) EP1148875B1 (https=)
JP (2) JP4968868B2 (https=)
KR (1) KR100643553B1 (https=)
CN (1) CN1310642C (https=)
AP (1) AP1497A (https=)
AT (1) ATE268597T1 (https=)
AU (2) AU772979B2 (https=)
BR (1) BR0007924A (https=)
CA (1) CA2361587C (https=)
CZ (1) CZ20012698A3 (https=)
DE (1) DE60011391T2 (https=)
DK (1) DK1148875T3 (https=)
ES (1) ES2222174T3 (https=)
HK (1) HK1038319B (https=)
HU (1) HUP0200100A3 (https=)
IL (1) IL144400A (https=)
MX (1) MXPA01007801A (https=)
NO (1) NO20013770L (https=)
NZ (1) NZ513602A (https=)
PT (1) PT1148875E (https=)
SI (1) SI1148875T1 (https=)
TR (1) TR200102239T2 (https=)
WO (1) WO2000045814A1 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506770B1 (en) 1996-06-06 2003-01-14 Anormed, Inc. Antiviral compounds
DE60042030D1 (de) * 1999-12-17 2009-05-28 Genzyme Corp Chemokinrezeptor-bindende heterocyclische verbindungen
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
PT1317451E (pt) * 2000-09-15 2006-12-29 Anormed Inc Compostos heterocíclicos que se ligam a receptores de quimioquinas
US6835731B2 (en) * 2000-09-15 2004-12-28 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
AU2002211393B2 (en) 2000-09-29 2007-06-28 Anormed Inc. Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof
US7169750B2 (en) * 2001-07-31 2007-01-30 Anormed, Inc. Methods to mobilize progenitor/stem cells
ES2380009T3 (es) * 2001-07-31 2012-05-07 Genzyme Global S.A.R.L. Métodos para movilizar las células madre/progenitoras
WO2003022785A2 (en) * 2001-09-12 2003-03-20 Anormed Inc. Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
CA2467718C (en) * 2001-12-21 2011-04-26 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
US7354932B2 (en) 2001-12-21 2008-04-08 Anormed, Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
WO2004020462A1 (ja) 2002-08-27 2004-03-11 Fujii, Nobutaka Cxcr4拮抗薬およびその用途
EP1613613B1 (en) * 2003-04-11 2021-06-02 Genzyme Corporation Cxcr4 chemokine receptor binding compounds
AU2004232361A1 (en) 2003-04-22 2004-11-04 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
US7501518B2 (en) * 2003-04-22 2009-03-10 Genzyme Corporation Methods of making 2,6-diaryl piperidine derivatives
US7498346B2 (en) * 2003-12-11 2009-03-03 Genzyme Corporation Chemokine receptor binding compounds
EP1708703A4 (en) * 2003-12-11 2008-04-09 Anormed Inc CHEMOKIN RECEPTOR BINDING COMPOUNDS
JP2008509928A (ja) * 2004-08-13 2008-04-03 アノーメド インコーポレイテッド 前駆/幹細胞を動員するためのケモカインの組み合わせ
EP1942890A4 (en) * 2005-06-15 2009-08-26 Genzyme Corp CHEMOKINE RECEPTOR BINDING COMPOUNDS
EP1924265A4 (en) * 2005-08-16 2010-06-02 Genzyme Corp COMPOUNDS BINDING TO CHEMOKINE RECEPTORS
MX2008010895A (es) * 2006-02-24 2008-09-03 Genzyme Corp Metodos para aumentar el flujo sanguineo y/o promover la regeneracion de tejidos.
AU2007281090A1 (en) * 2006-08-02 2008-02-07 Genzyme Corporation Combination therapy
JP2010507567A (ja) * 2006-08-07 2010-03-11 ジェンザイム・コーポレーション 併用療法
CA2673719C (en) * 2006-12-21 2018-07-24 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
US9427456B2 (en) 2009-06-14 2016-08-30 Biokine Therapeutics Ltd. Peptide therapy for increasing platelet levels
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
RU2638802C2 (ru) * 2011-05-16 2017-12-15 Джензим Корпорейшн Применение антагонистов cxcr4
US9439942B2 (en) 2012-04-24 2016-09-13 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
IL274572B2 (en) 2015-07-16 2024-01-01 Biolinerx Ltd Compositions and methods for treating cancer
CN109069426B (zh) 2015-12-14 2021-10-29 X4 制药有限公司 治疗癌症的方法
WO2017106332A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
PL3393468T3 (pl) 2015-12-22 2023-01-23 X4 Pharmaceuticals, Inc. Metody leczenia niedoboru odporności
CN109310733A (zh) 2016-02-23 2019-02-05 百欧林纳克斯有限公司 治疗急性骨髓性白血病的方法
US11337969B2 (en) 2016-04-08 2022-05-24 X4 Pharmaceuticals, Inc. Methods for treating cancer
CN109640988A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
ES2870920T3 (es) 2016-06-21 2021-10-28 X4 Pharmaceuticals Inc Inhibidores de CXCR4 y usos de los mismos
WO2017223243A1 (en) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
CN109187337A (zh) * 2018-09-10 2019-01-11 南京工业职业技术学院 一种筛选强韧性FeAl晶界的方法
CA3171250A1 (en) 2020-03-10 2021-09-16 E. Lynne KELLEY Methods for treating neutropenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
US5021409A (en) 1989-12-21 1991-06-04 Johnson Matthey Plc Antiviral cyclic polyamines
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
GB9400411D0 (en) 1994-01-11 1994-03-09 Johnson Matthey Plc Improvements in chemical compounds
US5612478A (en) 1995-03-30 1997-03-18 Johnson Matthey Plc Process for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane
US5606053A (en) 1995-05-02 1997-02-25 Johnson Matthey Plc Process for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane
US6506770B1 (en) 1996-06-06 2003-01-14 Anormed, Inc. Antiviral compounds
GB9511357D0 (en) 1995-06-06 1995-08-02 Johnson Matthey Plc Improved antiviral compounds
JP2002529502A (ja) * 1998-11-17 2002-09-10 スミスクライン・ビーチャム・コーポレイション 血小板減少症の治療法

Similar Documents

Publication Publication Date Title
JP2002536329A5 (https=)
CA2361587A1 (en) Methods and compositions to enhance white blood cell count
RU2225389C2 (ru) Производные аминометилкарбоновой кислоты и фармацевтическая композиция на их основе
JP5137288B2 (ja) 前駆/幹細胞を動員する方法
JP2003519676A5 (https=)
JP2008509928A5 (https=)
RU2004119406A (ru) 5-сульфанил-4н-1,2,4-триазольные производные и их применение в качестве лекарственного препарата
DE69925141D1 (de) Chinazolin derivate
WO2005113537B1 (en) Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
JP2004523561A5 (https=)
KR960014125A (ko) 헤테로사이클 화합물, 이들의 제조방법 및 용도
HUP0004529A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk
JP2008510828A5 (https=)
CA2369560A1 (en) Agent for prophylaxis and treatment of liver disease
RU2394031C2 (ru) Соли четвертичного аммония в качестве антагонистов м3
MXPA05010816A (es) Derivados de 4-(4- (heterociclilalcox}fenil)- 1-(heterociclil- carbonil) piperidina y compuestos relacionados como antagonistas de h3 de la histamina para el tratamiento de enfermedades neurologicas tales como alzheimer.
RU98120057A (ru) Производные d-пролина
JP2001526218A5 (https=)
CA2281426A1 (en) Substituted indole compounds as anti-inflammatory and analgesic agents
EP0309422A3 (en) New amidino tricycle derivatives
JP2011510072A5 (https=)
JP2005526773A5 (https=)
CO5080752A1 (es) INHIBIDORES DEL FACTOR DE TRANSCRIPCION NF-kB
KR890001988A (ko) 치환된 알켄카복실산아미드 및 이의유도체
JP2005527518A (ja) 新規なカルコン(chalcone)誘導体とその使用